Coforge has successfully completed its acquisition of Encora US Holdco, Inc. and Encora Holdings Limited, marking a key milestone in its growth strategy. As part of this transaction, the company has secured a USD 550 million loan facility to fund the investment. Additionally, Coforge has bolstered its leadership team by appointing Shweta Jalan and Atin Hirachand Jain as Additional Directors, effective April 23, 2026, to strengthen its strategic oversight.
Acquisition and Funding Details
Following the initial agreement announced on December 26, 2025, Coforge has finalized the acquisition of Encora US Holdco, Inc. and Encora Holdings Limited. To support this investment, the company has entered into a USD 550 million facilities agreement with a consortium of lenders, including JPMorgan Chase Bank, N.A., Bank of America, Citibank, HSBC, and BNP Paribas. The loan is structured as a secured facility with a 3-year tenor.
Preferential Share Allotment
As part of the transaction’s consideration, Coforge has allotted 9,37,96,508 equity shares on a preferential basis to Encora Holdco Limited and AI Altius Parent (Cayman) Limited. The shares were issued at a price of INR 1,815.91 per share, resulting in an aggregate consideration of approximately INR 17,032.60 crore. This move brings the company’s total issued and paid-up capital to 42,96,47,126 shares.
Board of Directors Expansion
Coforge has also strengthened its governance framework with the appointment of two new Non-Executive Directors. Shweta Jalan, a Managing Partner at Advent Private Equity, and Atin Hirachand Jain, a Director at Advent Private Equity, join the board effective April 23, 2026. These appointments are subject to shareholder approval and bring extensive experience in technology and healthcare investment to the organization.
Source: BSE
